Our results show that patients with a more severe necroinflammatory process (METAVIR A2 score), which is usually characteristic of a faster progression of liver fibrosis, have higher transaminase levels and lower intrahepatic TLR3 and IFNL3 expressions. This evidence concerns the gene TLR3 and Hepatic fibrosis.